Skip to main content
. 2022 Sep 22;14(19):4606. doi: 10.3390/cancers14194606

Figure 4.

Figure 4

Overall survival (months) of patients treated with Docetaxel estimated by Kaplan–Meier stratified by Neutrophil to Lymphocyte ratio (NLR) score: Good (NLR ≤ 5 at baseline and ≤5 at 12 weeks), Intermediate (NLR ≤ 5 at baseline and >5 at 12 weeks) and Poor (NLR > 5 at baseline and at 12 weeks).